What Antibiotics Can I Take If I’m Allergic to Penicillin?

If you have a penicillin allergy label on your chart, several classes of antibiotics are available to you, including macrolides like azithromycin, fluoroquinolones like levofloxacin, and in many cases cephalosporins and carbapenems, which are structurally related to penicillin but carry very low cross-reactivity risk. The more interesting part of the story, though, is that the allergy label itself may be wrong, and that matters more than most people realize.

Why Your Penicillin Allergy Label Might Be Inaccurate

Roughly one in ten people in Western countries carry a penicillin allergy label in their medical records. But the vast majority of those labels are inaccurate. Many were applied in childhood after a rash that was actually caused by a virus rather than the antibiotic. Others reflect a genuine reaction that occurred decades ago but has since resolved on its own, which happens in about 80 percent of cases within ten years. The result is an enormous population of people avoiding penicillins for no current medical reason.

In children, this misattribution problem is especially well documented. A study of 88 children who had developed mild, delayed skin rashes while taking penicillin found that the rashes were often unrelated to the drug itself. When these children were carefully re-exposed to penicillin under medical supervision, the reactions frequently did not recur, suggesting the original rash was caused by the underlying viral illness rather than the antibiotic.¹ This is one of the most common ways a lifelong allergy label gets started: a toddler gets a rash while on amoxicillin, the parents understandably report it as an allergy, and the label follows the child into adulthood without ever being verified.

The Real Risks of Keeping a Wrong Allergy Label

Carrying a penicillin allergy label, even if it is inaccurate, changes the antibiotics you receive in meaningful ways. A large population-based study found that patients with a penicillin allergy label were prescribed macrolide antibiotics at roughly four times the rate of matched patients without the label, clindamycin at nearly four times the rate, and fluoroquinolones at about twice the rate.² These substitute antibiotics are broader-spectrum, meaning they kill a wider range of bacteria, including beneficial ones. That shift has consequences.

The same study found that patients with a penicillin allergy label had a roughly 69 percent higher risk of MRSA infection and a 26 percent higher risk of C. difficile infection compared to patients without the label. More than half of the increased MRSA risk was statistically traceable to the use of alternative antibiotic classes, particularly fluoroquinolones, clindamycin, and macrolides.² A separate UK cohort study confirmed the pattern: patients labeled as antibiotic-allergic were more likely to receive broad-spectrum alternatives and had higher rates of both MRSA and C. difficile.³

In plain terms, the allergy label does not just limit your options. It nudges your care toward antibiotics that are more likely to breed resistant infections. That is why allergists and infectious-disease specialists have been pushing hard for allergy “delabeling” programs.

Getting Tested to Remove or Confirm the Label

Penicillin allergy testing typically involves a skin prick test, followed by an intradermal injection of a tiny amount of penicillin reagent, and then an observed oral challenge where you actually take a dose of penicillin under medical supervision. The process takes a few hours and is very safe when performed in a clinical setting. In one study of 169 patients who underwent both skin testing and oral challenges, reactions to the oral challenge were mild rashes occurring in a small percentage of cases, and no serious adverse events were reported.⁴ At follow-up two to six years later, only about 5 percent of patients who went on to receive full courses of penicillin developed a mild skin eruption.

This testing is also cost-effective. An economic evaluation found that penicillin allergy testing saved an average of about $650 per inpatient and about $2,750 per outpatient across models built from US and European data. In three-quarters of probabilistic simulations, testing came out as the cheaper option compared to continued avoidance of penicillins.⁵ A separate prospective study of hospitalized patients found that after delabeling, the median antibiotic treatment cost dropped significantly when patients were switched to beta-lactams.⁶

The benefits go beyond cost. A multicenter delabeling program found that patients who had their allergy label removed were more than ten times as likely to receive narrow-spectrum penicillins, about half as likely to receive restricted antibiotics, and significantly less likely to receive an inappropriate prescription.⁷ “Inappropriate” here means an antibiotic that was broader than necessary or less effective for the infection being treated.

When You Really Are Allergic, Cephalosporins Are Often Still Safe

Cephalosporins belong to the same beta-lactam family as penicillins, so for decades there was a blanket warning to avoid them if you were penicillin-allergic. That advice turned out to be far too cautious. The older estimate of 10 percent cross-reactivity between penicillins and cephalosporins was based on studies from the 1960s and 1970s, when early cephalosporins were sometimes contaminated with trace penicillin during manufacturing. Modern data paint a much more reassuring picture.

The key insight is that cross-reactivity between penicillins and cephalosporins is driven primarily by the chemical side chains attached to the beta-lactam ring, not by the ring structure itself. Specifically, the R1 side chain is the main determinant.⁸ An Australian cohort study confirmed that R1 side-chain groups explained most test outcomes when evaluating cephalosporin allergy.⁹

What this means practically is that many cephalosporins have side chains that look nothing like those on penicillin, making cross-reactivity extremely unlikely. Cefazolin, for example, the most widely used cephalosporin for surgical prophylaxis, has a unique R-group structure that makes it safe for the vast majority of patients with confirmed penicillin allergy, including those who had immediate (type 1) hypersensitivity reactions.¹⁰ Others, like cephalexin and cefadroxil, share a side chain with amoxicillin, so those specific combinations carry more risk and are best avoided unless allergy testing clears you.

Carbapenems and Monobactams

Carbapenems (meropenem, imipenem, ertapenem) are powerful beta-lactam antibiotics reserved for serious infections. Despite being in the same broad family as penicillins, the actual cross-reactivity rate is very low. A meta-analysis of eleven observational studies involving over 1,100 penicillin-allergic patients found a cross-reactivity rate to carbapenems of under 1 percent.¹¹ Earlier reviews also reported the incidence at around 1 percent based on prospective skin-test studies.¹²

Monobactams are a different story altogether. Aztreonam, the only commercially available monobactam, has a beta-lactam ring but lacks the second ring structure found in penicillins, cephalosporins, and carbapenems. There is no meaningful cross-reactivity between aztreonam and penicillins, and many prescribers use it freely in penicillin-allergic patients. One important caveat: aztreonam shares a side chain with ceftazidime, a specific cephalosporin, so people allergic to ceftazidime should be cautious with aztreonam and vice versa.¹²

Non-Beta-Lactam Alternatives

When your allergy is confirmed or when the clinical situation calls for a completely different drug class, several non-beta-lactam antibiotic families are available. Each has strengths and limitations, and the right choice depends on the infection being treated.

Macrolides: Azithromycin, clarithromycin, and erythromycin are commonly used for respiratory tract infections, certain skin infections, and sexually transmitted infections. They have been widely reported as successful substitutes for penicillin in allergic patients when treating infections for which penicillin would otherwise be first-line.¹³ Azithromycin in particular is popular because it has a short course (often three to five days), good tolerability, and broad availability.
Fluoroquinolones: Levofloxacin, moxifloxacin, and ciprofloxacin cover a wide range of gram-negative and some gram-positive bacteria. A study of patients with confirmed penicillin hypersensitivity found a positive reaction rate of only about 2.6 percent on fluoroquinolone oral provocation testing, suggesting they are a viable alternative in penicillin-allergic patients without a history of reacting to multiple drug classes.¹⁴ That said, fluoroquinolones carry their own risks, including tendon damage, nerve problems, and a contribution to antibiotic resistance, so they are best reserved for infections where other options are inadequate.
Clindamycin: Effective against many gram-positive bacteria and anaerobes, clindamycin is a common substitute for penicillin in skin and soft tissue infections and dental infections. Its main drawback is an elevated risk of C. difficile colitis.
Vancomycin: Often used intravenously for serious gram-positive infections like MRSA, vancomycin is also a common substitute for surgical prophylaxis in penicillin-allergic patients. It requires IV administration and careful dosing to avoid kidney and hearing toxicity.
Trimethoprim-sulfamethoxazole: This combination antibiotic covers urinary tract infections, some skin infections, and certain types of pneumonia. It is structurally unrelated to penicillin and carries no cross-reactivity risk.
Tetracyclines: Doxycycline is commonly prescribed for respiratory infections, acne, Lyme disease, and certain sexually transmitted infections. It is a versatile option with no structural relationship to penicillins.

The trade-off with all of these alternatives is that they tend to be either broader-spectrum than penicillins (killing more types of bacteria, including helpful ones) or narrower in coverage for specific infections. Penicillins remain first-line for many common conditions because they are cheap, effective, well-studied, and relatively gentle on the body’s normal bacterial populations. Substitutes work, but they are not always as good a fit.

Penicillin Allergy in Pregnancy

Pregnancy is one of the settings where a penicillin allergy label causes the most trouble. Penicillin is the recommended treatment for syphilis in pregnancy (no alternative is considered adequate for preventing congenital syphilis) and is first-line prophylaxis for Group B Streptococcus (GBS), which can cause life-threatening infections in newborns during delivery. Cefazolin is first-line for cesarean section prophylaxis.

A study of pregnant women with penicillin allergy labels who received an in-person allergy evaluation found dramatic improvements in antibiotic use. Those who were evaluated were about 27 times more likely to receive penicillin for GBS prophylaxis and roughly twice as likely to receive cefazolin for cesarean section prophylaxis, compared to those who were not evaluated. Their use of vancomycin dropped by more than 90 percent, and clindamycin use fell by more than 80 percent.¹⁵ These are not small adjustments; they represent a wholesale return to first-line, evidence-backed therapy that was being denied because of an unverified allergy label.

For the small number of pregnant women who are confirmed penicillin-allergic and need treatment for syphilis, desensitization protocols exist. One program performed oral desensitization on ten pregnant patients with confirmed penicillin allergy, gradually exposing them to increasing doses under close medical supervision. All patients tolerated the procedure without adverse reactions and went on to receive full penicillin treatment.¹⁶ Desensitization is not a permanent fix; it temporarily makes the immune system tolerant while the drug is being administered, and the allergy returns once treatment stops. But it allows life-saving treatment to proceed safely.

Surgical Prophylaxis and the Cefazolin Question

Before most surgeries, you receive a dose of antibiotics to prevent wound infections. Cefazolin is the standard choice for the majority of procedures. When a patient has a penicillin allergy label, surgeons and anesthesiologists often switch to vancomycin or clindamycin instead. Those alternatives provide less comprehensive coverage and come with their own side effects, including the so-called “red man syndrome” with vancomycin (a histamine-mediated flushing reaction that requires slow infusion and is often mistaken for an allergy itself).

Because cefazolin has unique R-group side chains that differ from those on penicillin, it is considered safe for the vast majority of penicillin-allergic patients, even those with a history of immediate reactions.¹⁰ Programs that incorporate preoperative allergy evaluation, skin testing, or clinician-guided algorithms have significantly increased cefazolin use in labeled patients without a corresponding increase in allergic reactions.¹⁷ In other words, the fear of cross-reactivity has been causing real harm, pushing patients onto inferior prophylaxis for a risk that barely exists with this particular drug.

When Desensitization Makes Sense

For certain infections, penicillin is not just preferred; it is the only adequate treatment. Syphilis is the clearest example, but endocarditis (infection of the heart valves) caused by certain bacteria is another. In these scenarios, if you are confirmed allergic, desensitization is a practical option rather than an exotic one.

The procedure involves giving the drug in very small, progressively increasing doses over several hours, typically in an ICU or closely monitored setting. The immune system is gradually nudged into tolerance. This is temporary tolerance: if the drug is stopped and later restarted, the allergy can return, and the protocol must be repeated. The process is well-established, and serious reactions during properly conducted desensitization are rare, though medical teams stay prepared to treat anaphylaxis throughout.

Electronic Health Records and the Alert Fatigue Problem

One underappreciated factor keeping incorrect allergy labels in place is the way electronic health records handle drug allergy alerts. Every time a clinician tries to prescribe a beta-lactam antibiotic for a patient with a penicillin allergy label, the system fires a pop-up warning. These alerts are designed to prevent harm, but when most of the allergy labels they are protecting against are inaccurate, the alerts become noise. Clinicians who see hundreds of these warnings per week learn to click through them without reading carefully, a phenomenon called alert fatigue. When a genuinely dangerous allergy alert eventually comes along, it may get the same automatic dismissal as all the false ones.

Researchers and health systems have been exploring clinical decision support tools that go beyond a simple yes-or-no allergy alert. Some systems now guide clinicians through a structured assessment of the allergy history, helping them distinguish high-risk patients (those with a history of anaphylaxis or a recent confirmed reaction) from low-risk ones (those with a distant childhood rash). Mobile apps and EHR-integrated tools aimed at facilitating penicillin allergy delabeling are being developed and tested, with early evidence suggesting they can reduce unnecessary beta-lactam avoidance.¹⁸ The goal is to make the allergy label smarter: not just a binary flag, but a risk-stratified assessment that tells clinicians what they can safely prescribe.

How to Approach Your Own Allergy Label

If you have a penicillin allergy in your medical record, the single most useful thing you can do is find out whether it is real. Ask your doctor for a referral to an allergist for formal testing. If your reaction was a childhood rash more than ten years ago, the odds are strongly in favor of the allergy having resolved. Even if your reaction was more serious, testing can clarify your actual risk and help clinicians choose antibiotics more confidently.

In the meantime, it helps to know as much as you can about your original reaction. When did it happen? What exactly occurred: hives, swelling, difficulty breathing, a flat rash, stomach upset? How soon after taking the antibiotic did it start? Immediate reactions (within an hour, involving hives, swelling, or anaphylaxis) are more likely to represent true IgE-mediated allergy. Delayed rashes appearing days into a course, especially in the context of a viral illness, are more likely to be benign and unrelated to true drug allergy. The more detail you can provide, the better your clinician can assess your risk and choose appropriate alternatives while you await formal testing.

If formal testing is not accessible right away and you need an antibiotic now, the alternatives described above are well-established. Your prescriber will choose based on the type of infection, the likely bacteria involved, and the severity of your reported reaction. For most routine infections, macrolides, fluoroquinolones, or doxycycline will cover what is needed. For surgical prophylaxis, cefazolin is likely safe even with a penicillin allergy label. For serious or life-threatening infections where penicillin is uniquely effective, desensitization remains an option in a supervised medical setting.